-+ 0.00%
-+ 0.00%
-+ 0.00%

ImmunityBio Reports ANKTIVA Plus BCG Achieves 96% Three-Year Survival in BCG-Unresponsive Bladder Cancer

Reuters·12/16/2025 14:01:44

Please log in to view news